239 related articles for article (PubMed ID: 9572542)
1. Distribution of verapamil and norverapamil in the eye and systemic circulation after topical administration of verapamil in rabbits.
Siegner SW; Giovanoni RL; Erickson KA; Netland PA
J Ocul Pharmacol Ther; 1998 Apr; 14(2):159-68. PubMed ID: 9572542
[TBL] [Abstract][Full Text] [Related]
2. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
[TBL] [Abstract][Full Text] [Related]
3. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
Dadashzadeh S; Javadian B; Sadeghian S
Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
[TBL] [Abstract][Full Text] [Related]
4. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
Kim HJ; Choi JS
Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
[TBL] [Abstract][Full Text] [Related]
5. Ocular pharmacokinetics of verapamil in rabbits.
Ettl A; Hofmann U; Daxer A; Dietrich H; Schmid E; Eichelbaum M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):331-5. PubMed ID: 9550306
[TBL] [Abstract][Full Text] [Related]
6. Retinal safety of oral and topical ofloxacin in rabbits.
Cohen RG; Raizman M; Callina C; Lahav M
J Ocul Pharmacol Ther; 1997 Aug; 13(4):369-79. PubMed ID: 9261772
[TBL] [Abstract][Full Text] [Related]
7. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of verapamil and norverapamil enantiomers after administration of immediate and controlled-release formulations to humans:evidence suggesting input-rate determined stereoselectivity.
Bhatti MM; Lewanczuk RZ; Pasutto FM; Foster RT
J Clin Pharmacol; 1995 Nov; 35(11):1076-82. PubMed ID: 8626881
[TBL] [Abstract][Full Text] [Related]
9. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
Wei LC; Tsai TC; Tsai HY; Wang CY; Shen YC
Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
[TBL] [Abstract][Full Text] [Related]
11. Ocular pharmacokinetics profile of different indomethacin topical formulations.
Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of verapamil and norverapamil in biological samples by high-performance liquid chromatography using ultraviolet detection.
Garcia MA; Aramayona JJ; Bregante MA; Fraile LJ; Solans C
J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):377-82. PubMed ID: 9210442
[TBL] [Abstract][Full Text] [Related]
13. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.
Choi JS; Burm JP
Arch Pharm Res; 2005 Apr; 28(4):483-7. PubMed ID: 15918524
[TBL] [Abstract][Full Text] [Related]
15. Topical versus intravenous administration of tranexamic acid: a comparison of intraocular and serum concentrations in the rabbit.
Damji KF; Noël LP; Peterson RG; Ma PE; Clarke WN; Gilberg S; Crouch ER; Williams PB
Can J Ophthalmol; 1998 Oct; 33(6):308-13. PubMed ID: 9818127
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
Bakri SJ; Snyder MR; Reid JM; Pulido JS; Ezzat MK; Singh RJ
Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
[TBL] [Abstract][Full Text] [Related]
17. Measurement of intraocular concentrations of etoposide after systemic and local administration.
Mao Y; Wu Z; Yang H; Lin S; Zheng J
Yan Ke Xue Bao; 2004 Sep; 20(3):178-80, 186. PubMed ID: 15499727
[TBL] [Abstract][Full Text] [Related]
18. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
[TBL] [Abstract][Full Text] [Related]
19. The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil.
Gupta SK; Yih BM; Atkinson L; Longstreth J
J Clin Pharmacol; 1995 Nov; 35(11):1083-93. PubMed ID: 8626882
[TBL] [Abstract][Full Text] [Related]
20. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
